These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27789108)

  • 1. "Aberrant" Papillary Muscle in a High-Endurance Athlete? The Importance of Advanced Cardiac Imaging.
    Saavedra LE; Lucena EM; Michelena HI
    Can J Cardiol; 2017 Feb; 33(2):293.e7-293.e8. PubMed ID: 27789108
    [No Abstract]   [Full Text] [Related]  

  • 2. Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management.
    Rowin EJ; Maron BJ; Lesser JR; Rastegar H; Maron MS
    Am J Cardiol; 2013 Jun; 111(11):1677-9. PubMed ID: 23499271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality imaging in the diagnosis of a large accessory papillary muscle.
    El Meligy A; Rasla S; Wheeler A; Souaid R; Noonan T
    R I Med J (2013); 2017 Sep; 100(9):33-36. PubMed ID: 28873484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death.
    La Gerche A; Baggish AL; Knuuti J; Prior DL; Sharma S; Heidbuchel H; Thompson PD
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):993-1007. PubMed ID: 24029371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy.
    Cavalcante JL; Barboza JS; Lever HM
    Prog Cardiovasc Dis; 2012; 54(6):517-22. PubMed ID: 22687594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atlantis Massif.
    Shah RG; Kirsch J
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1279-80. PubMed ID: 21222038
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple imaging assessment of chest pain in a case of apical hypertrophic cardiomyopathy: clinical, electrocardiographic, computed tomography angiography, and cardiac magnetic resonance imaging findings.
    de la Pena-Almaguer E; Madrid-Viteri X; Zamarripa-Morales R; DeFrance T
    J Cardiovasc Comput Tomogr; 2008; 2(2):126-8. PubMed ID: 19083935
    [No Abstract]   [Full Text] [Related]  

  • 9. Left ventricular dynamic obstruction by atypical papillary muscle morphology: is this finding so unusual in clinical practice?
    de Gregorio C
    J Am Soc Echocardiogr; 2007 Jan; 20(1):100-1. PubMed ID: 17218207
    [No Abstract]   [Full Text] [Related]  

  • 10. Solitary papillary muscle hypertrophy in young athletes: a rationale for inverted T-waves on ECG?
    de Gregorio C; Speranza G; Zagari D; Caruso R
    J Cardiovasc Med (Hagerstown); 2017 Sep; 18(9):702-703. PubMed ID: 23519097
    [No Abstract]   [Full Text] [Related]  

  • 11. Anomalous papillary muscle insertion in hypertrophic cardiomyopathy.
    Kadkhodayan A; Schaff HV; Eleid MF
    Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):588. PubMed ID: 26864188
    [No Abstract]   [Full Text] [Related]  

  • 12. EuroEcho-imaging 2017: highlights.
    Magne J; Bucciarelli-Ducci C; Dahl JS; Gimelli A; Haugaa KH; Miller O; Muraru D; Donal E; Edvardsen T; Popescu BA
    Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):482-489. PubMed ID: 29548013
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.
    Cardim N; Galderisi M; Edvardsen T; Plein S; Popescu BA; D'Andrea A; Bruder O; Cosyns B; Davin L; Donal E; Freitas A; Habib G; Kitsiou A; Petersen SE; Schroeder S; Lancellotti P; Camici P; Dulgheru R; Hagendorff A; Lombardi M; Muraru D; Sicari R
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):280. PubMed ID: 25650407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified surgical approach to symptomatic hypertrophic cardiomyopathy with abnormal papillary muscle morphology: Septal myectomy plus papillary muscle repositioning.
    Redaelli M; Poloni CL; Bichi S; Esposito G
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1709-11. PubMed ID: 24521966
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertrophic obstructive cardiomyopathy in combination with anomalous insertion of papillary muscle directly into anterior mitral leaflet and "sawfish" systolic narrowing of the left anterior descending coronary artery.
    Taşdemir O; Küçükaksu DS; Kural T; Bayazit K
    Tex Heart Inst J; 1994; 21(4):317-20. PubMed ID: 7888810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertrophic and restrictive cardiomyopathy. Differentiation by imaging].
    Fritschi S; Prothmann M; Schulz-Menger J
    Herz; 2015 Jun; 40(4):591-9. PubMed ID: 25963032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy mimicking STEMI: The role of cardiac magnetic resonance imaging in the detection of microvascular coronary dysfunction.
    Raissuni Z; Doghmi N; Mousseaux E; Cherti M; Redheuil A
    Diagn Interv Imaging; 2014 Nov; 95(11):1111-2. PubMed ID: 24560523
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic questions in hypertrophic cardiomyopathy: what is the significance of late enhancement on cardiac magnetic resonance?
    Almeida AG
    Rev Port Cardiol; 2014 May; 33(5):269-71. PubMed ID: 24909444
    [No Abstract]   [Full Text] [Related]  

  • 19. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
    ; Elliott PM; Anastasakis A; Borger MA; Borggrefe M; Cecchi F; Charron P; Hagege AA; Lafont A; Limongelli G; Mahrholdt H; McKenna WJ; Mogensen J; Nihoyannopoulos P; Nistri S; Pieper PG; Pieske B; Rapezzi C; Rutten FH; Tillmanns C; Watkins H
    Eur Heart J; 2014 Oct; 35(39):2733-79. PubMed ID: 25173338
    [No Abstract]   [Full Text] [Related]  

  • 20. Retrospective analysis of magnetic resonance myocardial delayed enhancement.
    Zhang ZH; Miao Q; Lin SB; Zhang SY; Li DJ; Chen LB; Zhang H; Wang YN; Zhou L; Kong LY; Feng F; You H; Sun HY; Zhao WM; Zhang LR; Jin ZY
    Chin Med Sci J; 2006 Dec; 21(4):245-51. PubMed ID: 17249200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.